VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹86 Cr | ₹37 Cr | ₹37 Cr | ₹41 Cr | ₹132 Cr |
What is the latest Cash Flow from Operating Activities ratio of VENUS REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹86 Cr |
| Mar2024 | ₹37 Cr |
| Mar2023 | ₹37 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹132 Cr |
How is Cash Flow from Operating Activities of VENUS REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹86 Cr | 131.84 | |
| Mar2024 | ₹37 Cr | 1.80 | |
| Mar2023 | ₹37 Cr | -10.89 | |
| Mar2022 | ₹41 Cr | -68.82 | |
| Mar2021 | ₹132 Cr | - | |
Compare Cash Flow from Operating Activities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,055.7 Cr | -9.7% | -22% | 190.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -9.7% |
-22% |
190.5% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses